Cizzle Biotechnology Holdings PLC
Research Cizzle Biotechnology Holdings PLC (CIZ) on Bullrun: market cap GBX 637.44M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCIZ
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyGBX
- Market capGBX 637.44M
- Financial periodFY2025
- RevenueGBP 0
- Net income-GBP 691.00K
- Free cash flow-GBP 498.00K
Valuation Snapshot
latest market cap is GBX 637.44M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 0 | -GBP 691.00K | -GBP 498.00K | n/a | 0 | GBP 116.00K | n/a | -GBP 340.00K |
| FY2024 | GBP 0 | -GBP 2.17M | -GBP 358.00K | n/a | -0.01 | GBP 365.00K | n/a | GBP 82.00K |
| FY2023 | GBP 0 | -GBP 1.72M | -GBP 639.00K | n/a | -0.01 | GBP 144.00K | n/a | GBP 1.51M |
| FY2022 | GBP 0 | -GBP 912.00K | -GBP 872.00K | n/a | 0 | GBP 478.00K | n/a | GBP 2.64M |
| FY2021 | GBP 0 | -GBP 3.92M | -GBP 1.21M | n/a | n/a | GBP 875.00K | GBP 0 | GBP 937.00K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | GBX 637.44M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About Cizzle Biotechnology Holdings PLC
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cizzle Biotechnology Holdings PLC's market cap?
Cizzle Biotechnology Holdings PLC's market capitalization is GBX 637.44M.
What does Cizzle Biotechnology Holdings PLC do?
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.